Writing Style

Voice: Expert but accessible. Write as a senior scientist who also knows how to communicate with non-specialists. Avoid marketing language.

Tense: Present tense for platform descriptions; future for pipeline goals.

Terminology rules:
  • Always: mAbV (not MABV, not mabv, not mAbVtech in public-facing contexts). Never use "mAbV" alone — always pair as "mAbV".
  • Correct: "prophylactic monoclonal antibody" (not "vaccine-replacement" or "super-vaccine").
  • Reference Beyfortus as a "commercial proof of concept for the monoclonal antibody prophylaxis model" (not as a competitor).
  • Avoid unvalidated claims: no "proven", "guaranteed", "approved"; use "designed to", "intended to", "in development".
  • No clinical claims, no regulatory statements, no efficacy figures.

Reading level target: Advanced but accessible — calibrated for clinicians, R&D professionals, and investors scanning quickly.

Headline formula: Short, factual, active. Max 10 words. Lead with outcome, not mechanism.

Body copy formula: One idea per paragraph. Max 4 sentences. Support with one specific fact or reference where possible.